Ukraine Trade Data of Label Pack Imports Under HS Code 3004

Lookup Ukraine trade data of label pack imports under HS code 3004. Check Ukraine import trading parters of label pack

 
shipment icon

85 Shipments Records (Demo)

3004  
DateHS CodeProduct DescriptionOrigin CountryQuantityUnitNet WeightTotal Value [USD] Importer Name
28/Apr/201730049000001.likarskyy remedy: heparyzyn injection, in 20 ml vials, 10 vials labeled carton pack ukrainian-language 2010pachok.�route of administration: intravenous.�atc code: a05v a. indications: improving excited funktsiyipechinky chronic diseases nky furnace.�active substance: monoamoniyuhlitsyryn yzatu glycyrrhizin equivalent to 40 mg, 400 mg hli tin, l-tsysteyinuhidrohlorydu 20mg.�excipients: sodium sulfite bezvo dnyy, sodium chloride, water for injection, concentrated ammonia solution.�serial number: 09170307. datavyhotovlennya: 10.03.2017r.�shelf life: 09.03.2020r.�mistytozonoruynuyuchyh not matter, not the narcotic drugs, psychotropic noyurechovynoyu and prekursorom.vyrobnyk: beijing kawin technology share-holding co., ltd.krayina production: cn.torhivelna brand: heparyzyn.�.CHINA******UA125100783.9021,896.14 ***** 16 More Columns Available along with Company Name and Other Details etc.
28/Apr/20173004900000"1.liky for people to put up for retail sale not in aerosol packaging: kombispazm (r), №100 tablets, 10 tablets in aluminum blister, 1 blister in a cardboard package, carton of 10 packs in bulk pack of cardboard labeling ukrainian language (active ingredient: 1 tablet contains: paracetamol 500 mg, dicyclomine hydrochloride 20 mg) .seriya: e17027 - 11700up.vyrobnyk: evertodzhen sayensyz life limited, indiya.krayina production: in. "INDIA******UA1250302,92743,290.00 *****
28/Apr/20173004900000"1. goods supplied by the budget program 2301400: medicinal products for the treatment of patients with chronic myeloid leukemia - art.796857 neopaks tablets, film coated shell, 100 mg 10 tablets in a blister, 12 blisters in kart.korob. from ukrainian label movoyu.mizhnarodna inn "" imatinib "" total - 3152 package. per pack of 120 tablets (378, 240 tablets) series: v09258, v09259, v09269, v09270, v09271 - 3070 packages exp.data: 08/2019 ( 368, 400 tablets) series: v09227 - 82 package exp.data: 12/2019 (9840 tablets) active ingredients composition: 1 tablet covered with film�s shell contains 100 mg imatinib (as imatinib mesylate) registration certificate: ua / 14939/01 / 01torhovelna brand: neopaksvyrobnyk intas pharmaceuticals limited (manufacturer responsible for producing "" in bulk "", primary and secondary packaging) indiyakrka, dd, novo mesto (manufacturer responsible for secondary packaging, the manufacturer responsible for batch control, batch release) sloveniyazayavnyk: krka, dd, novo mesto, slovenia - art.796858 neopakstabletky coated film membrane 400 10 mg tablets in a blister;�6 blisters in a cardboard label korobtsiz ukrainian movoyu.mizhnarodna inn "" imatinib "" total - 570 package.�60 tablets per pack, (34, 200 tablets) series: v09207 - 432 package exp.data: 05/2019 (25920 tablets) series: v09221 - 129 package exp.data: 06/2019 (7740 tablets) series: v09228 - 9 packaging exp.data: 12/2019 (540 tablets) composition of active substances: 1 tablet covered with film wrapper contains 400 mg of imatinib (imatinib mesylate in a) registration certificate: ua / 14939/01 / 02torhovelna brand: neopaksvyrobnyk intas pharmaceuticals limited (producer responsible for the production of "" in bulk "", primary and secondary packaging) indiyakrka, dd, novo mesto (manufacturer responsible for secondary packaging, in�robnyk responsible for batch control, batch release) sloveniyazayavnyk: krka, dd, novo mesto, slovenia "SLOVENIA******UA100070395.52197,466.00 *****
27/Apr/20173004900000"1. medicines for people for therapeutic use, put up for retailtrade not contain narcotics, psychotropic substances not aerozolniyupakovtsi: kohnifen, hard capsules 300 mg / 5 mg №30 of 10 capsules in blister, 3 blisters in a cardboard package with -720 labeling ukrainian language pack. diyucharechovyna -fenibutu 300 mg ipidakrynu hydrochloride 5 mg calculated as 100% anhydrous substance. №10117 series. noophen, hard capsules in 250 mg №20, on 10kapsul in a blister, 2 blisters in a carton with a pack -1764 marking ukrayinskoyumovoyu pack. the active substance - fe�nibutu 250 mg №140416 series. noofen 100, powder for oral, solution 100 mg / dose №15, in 1g of powder bags for powder 15paketykiv in a pack -1050 pack. the active substance - phenibut 100 mg. seriya№641216. olatropil, №30 capsules, 10 capsules in blister, 3 blisters vkartonniy pack labeled -6126 ukrainian language pack. active ingredient: gamma-aminobutyric acid 125 mg, 250 mg piracetam. №10117 series; seriya№30117. entrop t on abletky №20 100 mg 10 tablets in a blister�2 blisteryv pack cardboard pack -768.�the active substance -fenilpiratsetamu 100 mg.�№31116.vyrobnyk series: jsc "" olaynfarm "". country of origin: lv. "LATVIA******UA125030287.5637,643.92 *****
27/Apr/20173004900000"1.liky for people without content, antibiotics, alkaloids in, hormones, vitamins, retail, not aerosol packaging: finalgon �, ointment, according to 20g tube №1 complete with applicator / nonivamid, nikoboksylvyrobnyk hlobofarm farmatsoytishe produktsionz und handelshezelshaft mbh (production, packaging, labeling and batch control), austria; trademark - "" boehringer ingelheim rcv gmbh & co kg "". "AUSTRIA******UA11003073.446,352.80 *****
27/Apr/20173004900000"1. medicinal products for human use for therapeutic use. packaged for retail trade. inspra (r), film coated tablets, 25 mg, 10 tablets in a blister, 3 blisters in a cardboard box, 4 serum z413618 active active substances: 1 tablet contains: eplerenon 25 mg inspra (r), tablets covered with a film coat of 50 mg, 10 tablets in a blister, 3 blisters in a cardboard box-2 episode z410306 active active ingredients: 1 tablet contains: eplerenon 50 mg producer: neolpharma inc. (manufacture of perfumery "" in bulk "", primary packaging and control�bones), usa, fareva amboise (you start a series, packaging, labeling, rear ol quality at issue), france pfizer farmasyutikalz llc (production of the drug in bulk, and quality control), c shatorhivelna mark: pfizer, insprakrayina production: us. "UNITED STATES******UA1250300.11369.16 *****
26/Apr/20173004390000"1.liky for people containing hormones, for retail, not aerosol packaging: diferelin �, 0.1 mg powder and solvent for solution for injection, in vials of powder 7 and 7 vials with 1 ml of solvent ( sodium chloride 0.9%) in the box / tryptorelyn; diferelin �, to 3.75 mg powder and solvent for suspension for injection, sustained release, 1 vial of powder with solvent supplied in 2 ml vials, syringes for single and use two needles (in blister pack) / tryptorelyn acetate; producer: ipsen pharma biotech (threshold�ok: production, labeling and packaging, secondary packaging, quality control and production of the product; solvent: secondary packaging and batch release) frantsiyaseneksi (solvent: production, primary packaging and quality control), france; ".FRANCE******UA11012026.8025,214.19 *****
26/Apr/20173004390000"1. drugs (medicines for humans), in packages for retail, therapeutic or prophylactic, free of drugs and precursors containing hormones or other products of heading 2937 but without vmistuantybiotykiv not in aerosol packaging: diferelin (r ) powder for 3, 75mh, tarozchynnyk for suspension for prolonged release injection, 1 vial zporoshkom complete with 2 ml of solvent in (mannitol (e421), water for injection) vampuli, syringes for single use needles and two (in blisterniyupakovtsi ) in cardboard box�i. active ingredient: 1 vial contains: tryptorelinuatsetat corresponding to 3, 75mh triptorelin. series: m03682-2up. diferelin (r) powder for 11, 25mh and solvent for suspension for injection prolonhovanohovyvilnennya, 1 vial of powder supplied in 2 ml of diluent (mannitol (e421), water for injection) vials, syringes for single vykorystannyata two needles (in blister pack) in a cardboard box. active ingredient: 1flakon contains: triptorelin pamoate 15 mg, corresponding 11, 25mh triptorelin .seriya: l24368-5up.torhivelna mark - ipsen dyferelin.vyrobnyk: powder - you�robnytstvo, labeling and packaging, secondary packaging, quality control and release of medicinal product "" ipsen pharma biotech "" frantsiya.rozchynnyk - production, primary packaging and quality control "" seneksi "" france.�secondary packaging and a series of "" ipsen pharma biotech "" frantsiya.krayina production - france (fr).�marking vstanovlenymzakonodavstvom available and meets the standards. "FRANCE******UA1250300.29957.50 *****
25/Apr/20173004400000"1.liky for people containing alkaloids, packaged for retail sale not in aerosol packaging: paklimedak concentrate for solution for infusion 6 mg / ml to 5 ml (30 mg) in a vial №1 box / paclitaxel / producer medak gmbh ( manufacturer responsible for packaging, labeling and batch release), germany onkotek production pharma gmbh (manufacturer of finished dosage form), germany. "GERMANY******UA1101201.25596.64 *****
25/Apr/20173004900000"1.lika for people without content: vitamins, hormones, alkaloids, antibiotics, packaged for retail trade, not in aerosol packaging: asparaginase 5 000 medac, powder for solution for injection at 5 000 iu in vials №5 / asparaginase / manufacturer medac gesellschaft f�r cliene shpelsipreparate mbh (manufacturer responsible for labeling, secondary packaging and serial release), germanykyova hakko kirin co., ltd. (manufacturer responsible for the manufacture of the finished dosage form and primary packaging), japan; "JAPAN******UA1101200.351,491.60 *****
12345...90NextGoTo:
Need to access complete data?
loading icon

Get global trade data online at your fingertips

  
TERMS & CONDITIONS     |    CANCELATION POLICY     |    REFUND POLICY     |     PRIVACY POLICY
Copyright © 2021 Export Genius. All rights reserved